Wavefront-guided vs. Topography-guided LASIK
Launched by STANFORD UNIVERSITY · Oct 17, 2022
Trial Information
Current as of May 29, 2025
Completed
Keywords
ClinConnect Summary
The purpose of the study is to compare the results of wavefront-guided LASIK surgery to topography-guided LASIK surgery in participants with nearsightedness with or without astigmatism
Three FDA-approved laser devices are being used for the study.
Two excimer lasers are being used for the study. The excimer laser is used to perform the reshaping of the cornea under a LASIK flap to correct nearsightedness, farsightedness and astigmatism. The two lasers being utilized are the Johnson and Johnson Visx CustomVue excimer laser and the Alcon Allegretto laser in the study. Both have received FDA...
Gender
ALL
Eligibility criteria
- • Inclusion criteria.
- • Subjects ages 22 to 59with healthy eyes. Nearsightedness between -1.00 diopters and -9.00 diopters.
- • Subjects with less than or equal to 3.00 diopters of astigmatism.
- • Exclusion criteria.
- • Subjects under the age of 22 and over the age of 59
- • Subjects with excessively thin corneas.
- • Subjects with topographic evidence of keratoconus.
- • Subjects with ectactic eye disorders.
- • Subjects with autoimmune diseases.
- • Subjects who are pregnant or nursing.
- • Subjects must have similar levels of nearsightedness in each eye. They cannot be more than 1.5 diopter of difference between eyes.
- • Subjects with more than 3.00 diopters of astigmatism
- • Subjects must have similar levels of astigmatism in each eye. They cannot have more than 1.00 diopters of difference between eyes.
About Stanford University
Stanford University is a prestigious academic institution renowned for its cutting-edge research and innovation in healthcare and medicine. As a clinical trial sponsor, Stanford leverages its extensive resources, including a collaborative network of world-class researchers and state-of-the-art facilities, to advance medical knowledge and improve patient care. The university is committed to conducting rigorous, ethical research that adheres to the highest standards of scientific integrity, fostering an environment where groundbreaking discoveries can translate into effective clinical applications. Through its clinical trials, Stanford aims to address critical health challenges and contribute to the development of novel therapies and treatment strategies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Palo Alto, California, United States
Patients applied
Trial Officials
Edward E Manche, MD
Principal Investigator
Stanford University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials